Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Levente Endre Dókus, Mo’ath Yousef & Zoltán Bánóczi. (2020) Modulators of calpain activity: inhibitors and activators as potential drugs. Expert Opinion on Drug Discovery 15:4, pages 471-486.
Read now
Read now
Jesse S. Dondapati, Sudhakar Godi & Ajay P. Babu. (2008) QSAR studies on peptide α-ketoamides and α-ketohydroxamate derivatives as calpain I inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 23:6, pages 757-762.
Read now
Read now
Rodney Guttmann. (2007) Recent developments in the therapeutic targeting of calpains in neurodegeneration. Expert Opinion on Therapeutic Patents 17:10, pages 1203-1213.
Read now
Read now
Articles from other publishers (32)
Dhira Joshi, Jennifer C. Milligan, Theresa U. Zeisner, Nicola O'Reilly, John F. X. Diffley & George Papageorgiou. (2021) An improved method for the incorporation of fluoromethyl ketones into solid phase peptide synthesis techniques. RSC Advances 11:33, pages 20457-20464.
Crossref
Crossref
Omid Reza Tamtaji, Naghmeh Mirhosseini, Russel J. Reiter, Abolfazl Azami & Zatollah Asemi. (2018) Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives. Journal of Cellular Physiology 234:2, pages 1001-1007.
Crossref
Crossref
Ashok D. Pehere, Steven Nguyen, Sarah K. Garlick, Danny W. Wilson, Irene Hudson, Matthew J. Sykes, James D. Morton & Andrew D. Abell. (2019) Tripeptide analogues of MG132 as protease inhibitors. Bioorganic & Medicinal Chemistry 27:2, pages 436-441.
Crossref
Crossref
Fany BlancLaetitia FurioDorothée MoisyHui-Ling YenMichel ChignardEmmanuel LetavernierNadia NaffakhChris Ka Pun MokMustapha Si-Tahar. (2016) Targeting host calpain proteases decreases influenza A virus infection. American Journal of Physiology-Lung Cellular and Molecular Physiology 310:7, pages L689-L699.
Crossref
Crossref
Jing Fan, Clare M. Gladding, Liang Wang, Lily Y.J. Zhang, Alexandra M. Kaufman, Austen J. Milnerwood & Lynn A. Raymond. (2012) P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease. Neurobiology of Disease 45:3, pages 999-1009.
Crossref
Crossref
Donald J. AbrahamPhilippe G. Nantermet, Evan F. Shalen, Shankar Venkatraman, Hong Zhu & Robert J. Mark. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
447
828
.
Jian Xu, Pradeep Kurup, Yongfang Zhang, Susan M. Goebel-Goody, Peter H. Wu, Ammar H. Hawasli, Matthew L. Baum, James A. Bibb & Paul J. Lombroso. (2009) Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEP. The Journal of Neuroscience 29:29, pages 9330-9343.
Crossref
Crossref
José Pfizer, Irmgard Assfalg-Machleidt, Werner Machleidt & Norbert Schaschke. (2008) Inhibition of human μ-calpain by conformationally constrained calpastatin peptides. bchm 389:1, pages 83-90.
Crossref
Crossref
Yoshihisa ShirasakiMasazumi YamaguchiHiroyuki Miyashita. (2006) Retinal Penetration of Calpain Inhibitors in Rats After Oral Administration. Journal of Ocular Pharmacology and Therapeutics 22:6, pages 417-424.
Crossref
Crossref
Yoshihisa Shirasaki, Hiroyuki Miyashita & Masazumi Yamaguchi. (2006) Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl α-ketoamide derivatives containing pyridine moiety. Bioorganic & Medicinal Chemistry 14:16, pages 5691-5698.
Crossref
Crossref
Yoshihisa Shirasaki, Masayuki Nakamura, Masazumi Yamaguchi, Hiroyuki Miyashita, Osamu Sakai & Jun Inoue. (2006) Exploration of Orally Available Calpain Inhibitors 2: Peptidyl Hemiacetal Derivatives. Journal of Medicinal Chemistry 49:13, pages 3926-3932.
Crossref
Crossref
M. Lee Sanders & Isaac O. Donkor. (2006) A novel series of urea-based peptidomimetic calpain inhibitors. Bioorganic & Medicinal Chemistry Letters 16:7, pages 1965-1968.
Crossref
Crossref
Cyrille Lescop, Holger Herzner, Hervé Siendt, Reto Bolliger, Marco Henneböhle, Philipp Weyermann, Alexandre Briguet, Isabelle Courdier-Fruh, Michael Erb, Mark Foster, Thomas Meier, Josef P. Magyar & Andreas von Sprecher. (2005) Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy. Bioorganic & Medicinal Chemistry Letters 15:23, pages 5176-5181.
Crossref
Crossref
M. Windisch, B. Hutter-Paier, E. Grygar, E. Doppler & H. Moessler. (2005) N-PEP-12 – a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions. Journal of Neural Transmission 112:10, pages 1331-1343.
Crossref
Crossref
Yoshihisa Shirasaki, Hiroyuki Miyashita, Masazumi Yamaguchi, Jun Inoue & Masayuki Nakamura. (2005) Exploration of orally available calpain inhibitors: Peptidyl α-ketoamides containing an amphiphile at P3 site. Bioorganic & Medicinal Chemistry 13:14, pages 4473-4484.
Crossref
Crossref
Mayana Zatz & Alessandra Starling. (2005) Calpains and Disease. New England Journal of Medicine 352:23, pages 2413-2423.
Crossref
Crossref
Yibin Zeng, Qingshan Li, Robert P. Hanzlik & Jeffrey Aubé. (2005) Synthesis of a small library of diketopiperazines as potential inhibitors of calpain. Bioorganic & Medicinal Chemistry Letters 15:12, pages 3034-3038.
Crossref
Crossref
Ron Bihovsky, Ming Tao, John P. Mallamo & Gregory J. Wells. (2004) 1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors. Bioorganic & Medicinal Chemistry Letters 14:4, pages 1035-1038.
Crossref
Crossref
Isaac O. Donkor, Jie Han & Xiaozhang Zheng. (2003)
Design, Synthesis, Molecular Modeling Studies, and Calpain Inhibitory Activity of Novel α-Ketoamides Incorporating Polar Residues at the P
1
‘-Position
. Journal of Medicinal Chemistry 47:1, pages 72-79.
Crossref
Crossref
DARREL E. GOLL, VALERY F. THOMPSON, HONGQI LI, WEI WEI & JINYANG CONG. (2003) The Calpain System. Physiological Reviews 83:3, pages 731-801.
Crossref
Crossref
Wilfried Lubisch, Edith Beckenbach, Sabina Bopp, Hans-Peter Hofmann, Arzu Kartal, Claudia Kästel, Tanja Lindner, Marion Metz-Garrecht, Jutta Reeb, Ferdinand Regner, Michael Vierling & Achim Möller. (2003) Benzoylalanine-Derived Ketoamides Carrying Vinylbenzyl Amino Residues: Discovery of Potent Water-Soluble Calpain Inhibitors with Oral Bioavailability. Journal of Medicinal Chemistry 46:12, pages 2404-2412.
Crossref
Crossref
Isaac O. Donkor, Rajani Korukonda, Tien L. Huang & Louis LeCourJr.Jr.. (2003) Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics. Bioorganic & Medicinal Chemistry Letters 13:5, pages 783-784.
Crossref
Crossref
W. Lubisch & A. Möller. (2002) Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors. Bioorganic & Medicinal Chemistry Letters 12:10, pages 1335-1338.
Crossref
Crossref
Gregory J. Wells, Ming Tao, Kurt A. Josef & Ron Bihovsky. (2001)
1,2-Benzothiazine 1,1-Dioxide P
2
−P
3
Peptide Mimetic Aldehyde Calpain I Inhibitors
. Journal of Medicinal Chemistry 44:21, pages 3488-3503.
Crossref
Crossref
Kurt A Josef, Frederick W Kauer & Ron Bihovsky. (2001) Potent peptide α-Ketohydroxamate inhibitors of recombinant human calpain I. Bioorganic & Medicinal Chemistry Letters 11:19, pages 2615-2617.
Crossref
Crossref
Isaac O. Donkor, Xiaozhang Zheng, Jie Han, Calvin Lacy & Duane D. Miller. (2001) Significance of Hydrogen Bonding at the S1′ Subsite of Calpain I. Bioorganic & Medicinal Chemistry Letters 11:13, pages 1753-1755.
Crossref
Crossref
Donald L. Mykles. 2001. Apoptosis. Apoptosis
247
287
.
Marc R. Del Bigio. (2000) Calcium-Mediated Proteolytic Damage in White Matter of Hydrocephalic Rats?. Journal of Neuropathology & Experimental Neurology 59:11, pages 946-954.
Crossref
Crossref
Isaac O Donkor, Xiaozhang Zheng & Duane D Miller. (2000) Synthesis and calpain inhibitory activity of α-ketoamides with 2,3-methanoleucine stereoisomers at the P2 position. Bioorganic & Medicinal Chemistry Letters 10:22, pages 2497-2500.
Crossref
Crossref
Rabindranath Tripathy, Mark A. Ator & John P. Mallamo. (2000) Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents. Bioorganic & Medicinal Chemistry Letters 10:20, pages 2315-2319.
Crossref
Crossref
W. Lubisch, H.P. Hofmann, H.J. Treiber & A. Möller. (2000) Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors. Bioorganic & Medicinal Chemistry Letters 10:19, pages 2187-2191.
Crossref
Crossref
Norton P. Peet, Hwa-Ok Kim, Angela L. Marquart, Michael R. Angelastro, Thaddeus R. Nieduzak, Julie N. White, Dirk Friedrich, Gary A. Flynn, Mark E. Webster, Roy J. Vaz, Matthew D. Linnik, Jack R. Koehl, Shujaath Mehdi, Philippe Bey, Bart Emary & Kin-Kai Hwang. (1999) Hydroxyoxazolidines as α-aminoacetaldehyde equivalents: Novel inhibitors of calpain. Bioorganic & Medicinal Chemistry Letters 9:16, pages 2365-2370.
Crossref
Crossref